Skip to Content
scroll

What’s MM’s thought’s towards Mayne Pharma (MYX)?

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

The Latest Q&A

Question asked

What’s MM’s thought’s towards Mayne Pharma (MYX)?

Hi James, I would just like your opinion on Mayne Pharma. Since mid August there has been a continued decline in market value. Their recent results presentation painted a confident outlook and profit projections but it all seems to be based on the future sale of Metrics Contract Services. I am wondering if I should take the loss and put my money elsewhere as the market is saying the risk reward has deteriorated. Keep up the great work. Kind regards John

Answer

Hi John,

Since plunging in both 2016 and 2018 Mayne Pharma (MYX) has hardly moved over the last 2-years albeit trading in a volatile range between 20c and 60c.

We see no reason to “play” in this choppy stock especially around the middle of the latest trading range. The company may deliver moving forward but until we see clear signs its unfortunately in the too hard basket for us.

 

chart
image description
Mayne Pharma Group Ltd (MYX)
image description

Relevant suggested news and content from the site

Back to top